康哲药业(00867.HK) 宣布,其自主研发的创新药INHBE小核酸药物CMS-D008注射液“CMS-D008”的临床前结果在第86届美国糖尿病协会(ADA)大会以壁报形式发布。ADA大会作为全球糖尿病及代谢疾病领域规模最大、最具权威影响力的年度学术风向标,此次汇聚了来自世界各地的超过12,000名顶尖临床专家、科研学者及一线医疗工作者,共同探讨与见证前沿诊疗成果与技术创新突破。CMS-...
Source Link康哲药业(00867.HK) 宣布,其自主研发的创新药INHBE小核酸药物CMS-D008注射液“CMS-D008”的临床前结果在第86届美国糖尿病协会(ADA)大会以壁报形式发布。ADA大会作为全球糖尿病及代谢疾病领域规模最大、最具权威影响力的年度学术风向标,此次汇聚了来自世界各地的超过12,000名顶尖临床专家、科研学者及一线医疗工作者,共同探讨与见证前沿诊疗成果与技术创新突破。CMS-...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.